Laureate Education(LAUR) - 2025 Q2 - Earnings Call Presentation
2025-07-31 12:30
Q2 2025 Performance - New Enrollments increased by 42% in Q2 2025 as reported[27] - Total Enrollment increased by 6% in Q2 2025 as reported, reaching 472,000[27] - Revenue increased by 5% to $524 million in Q2 2025 as reported[27] - Adjusted EBITDA increased by 15% to $214 million in Q2 2025 as reported[27] - Adjusted EBITDA margin increased by 348 bps to 409% in Q2 2025 as reported[27] - Year-to-date New Enrollments increased 7% and Total Enrollments increased 6%[18] H1 2025 Performance - Revenue was $760 million, a decrease of 2% as reported, but an increase of 6% organically[30] - Adjusted EBITDA was $220 million, an increase of 1% as reported, but an increase of 9% organically[30] - Adjusted EBITDA margin was 289%, an increase of 83 bps as reported[30] Capitalization and Share Count - Cash & Cash Equivalents totaled $135 million as of June 30, 2025[43] - Net Cash was $19 million as of June 30, 2025[43] - $71 million of shares were repurchased in H1 2025[43] 2025 Outlook - Revenue growth is expected at 3%-4% on a USD reported basis, and 6%-7% on an organic constant currency basis[50] - Adjusted EBITDA growth is expected at 9%-10% on a USD reported basis, and 11%-13% on an organic constant currency basis[50] - The company increased full-year 2025 guidance by $55 million for Revenue and $16 million for Adjusted EBITDA due to strengthening of MXN and PEN currencies[18]
Gannett(GCI) - 2025 Q2 - Earnings Call Presentation
2025-07-31 12:30
1 Disclaimer and Notes In General. This disclaimer applies to this document and the verbal or written comments of any person presenting it. This document, taken together with any such verbal or written comments, is referred to herein as the "Presentation." Gannett Co., Inc. is referred to in this Presentation as "Gannett," "we," "us," "our" or the "Company". Cautionary Statement Regarding Forward-Looking Statements. Certain items in this Presentation may constitute forward-looking statements within the mean ...
Vontier(VNT) - 2025 Q2 - Earnings Call Presentation
2025-07-31 12:30
Q2 2025 | Earnings Results July 31, 2025 Safe Harbor and Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the federal securities laws. These statements include, but are not limited to statements regarding Vontier Corporation's (the "Company's") business and acquisition opportunities, anticipated sales growth, anticipated adjusted operating margin expansion, anticipated adjusted net earnings per share, anticipated adjusted cash flow conversion, and antici ...
TreeHouse(THS) - 2025 Q2 - Earnings Call Presentation
2025-07-31 12:30
Q2 2025 Performance - Adjusted Net Sales reached $801.4 million, exceeding the upper end of guidance[7, 8] - Adjusted EBITDA was $73.3 million, also surpassing the upper end of guidance[7, 8] - Adjusted EBITDA margin increased by 20 bps to 9.1%[38] - Adjusted Net Sales increased 1.4% year-over-year[38, 40] Full Year 2025 Outlook - The company anticipates Adjusted EBITDA in the range of $345 million to $375 million[7] - Free Cash Flow is expected to be at least $130 million[7] - Adjusted Net Sales growth is projected to be between -0.5% and 1.0%, equating to $3.360 to $3.415 billion[7, 48] Sales Drivers - Volume/mix had a negative impact of (6.2)%, influenced by margin management and the griddle recall[40] - The Harris Tea acquisition contributed positively with 4.5%[40] - Pricing adjustments resulted in a benefit of 4.2%[40] Capital Allocation - Capital expenditures are planned at approximately $125 million to enhance capabilities in growing categories[44, 48]
APi (APG) - 2025 Q2 - Earnings Call Presentation
2025-07-31 12:30
Q2 2025 Performance - Net revenues reached $199 billion, a 150% increase compared to Q2 2024, with 83% organic growth[16, 20] - Adjusted EBITDA was $272 million, up 177% from Q2 2024, with adjusted EBITDA margin increasing by 30 basis points to 137%[16, 20] - Adjusted diluted earnings per share increased by 182% to $039 compared to Q2 2024[16, 20] - Year-to-date adjusted free cash flow was $186 million, a 388% increase year-over-year, representing 400% conversion[16] Segment Performance - Safety Services net revenues were $1362 billion, a 158% increase compared to Q2 2024, with 56% organic growth[22] - Specialty Services net revenues were $629 million, a 133% increase compared to Q2 2024, with 133% organic growth[22] - Safety Services adjusted gross profit was $506 million, a 179% increase, with adjusted gross margin at 372%[22] - Specialty Services adjusted gross profit was $114 million, a (50)% decrease, with adjusted gross margin at 181%[22] Guidance and Capitalization - The company projects net revenues of $7650 to $7850 million and adjusted EBITDA of $1005 to $1045 million for FY 2025[25, 26] - Q3 2025 net revenues are expected to be $1985 to $2035 million, with organic growth of 5%-7% and adjusted EBITDA of $270 to $280 million[26]
Belden(BDC) - 2025 Q2 - Earnings Call Presentation
2025-07-31 12:30
EARNINGS RESULTS July 2025 2 nd QUARTER 2025 Forward-Looking Statements and Non-GAAP Financial Measures Forward-Looking Statements Our commentary and responses to your questions may contain forward-looking statements, including our outlook for the third quarter of 2025 and beyond. Forward-looking statements include projections of sales, earnings, general economic conditions, market conditions, working capital, market shares, free cash flow, pricing levels, and effective tax rates. Belden disclaims any oblig ...
Comcast(CMCSA) - 2025 Q2 - Earnings Call Presentation
2025-07-31 12:30
Financial Performance - Comcast's revenue increased by 2.1% to $30.3 billion in 2Q25, compared to $29.7 billion in 2Q24 [6] - Adjusted EBITDA increased by 1.1% to $10.3 billion in 2Q25, compared to $10.2 billion in 2Q24 [6] - Adjusted EPS increased by 3.3% to $1.25 in 2Q25, compared to $1.21 in 2Q24 [6] - Free cash flow generation was $4.5 billion in 2Q25 [7, 15, 21] - The company returned $2.9 billion of capital to shareholders in 2Q25 [7, 14] Connectivity & Platforms - Connectivity & Platforms revenue decreased by 0.4% to $20.4 billion in 2Q25 [8] - Residential Connectivity revenue increased by 4%, driven by domestic wireless revenue (+17%), international connectivity revenue (+9%), and domestic broadband revenue (+2%) [8] - Business Services Connectivity revenue increased by 6.3% to $2.575 billion in 2Q25 [8] - Comcast added 378,000 wireless lines, achieving 14% penetration of domestic residential broadband customers [8] Content & Experiences - Content & Experiences revenue increased by 5.6% to $10.6 billion in 2Q25 [11] - Media revenue increased by 1.8% to $6.440 billion in 2Q25 [11] - Theme Parks revenue increased by 18.9% to $2.349 billion in 2Q25, driven by the successful opening of Epic Universe in Orlando [11] - Peacock revenue increased by 18% to $1.2 billion, with subscribers remaining steady at 41 million [11] - How to Train Your Dragon grossed over $600 million in worldwide box office [11, 40]
Apellis(APLS) - 2025 Q2 - Earnings Call Presentation
2025-07-31 12:30
Financial Performance - Apellis reported approximately $151 million in GA (Geographic Atrophy) revenue for 2Q 2025[10] - EMPAVELI U S net product sales were $208 million in 2Q 2025[18] - SYFOVRE U S net product sales were $1506 million in 2Q 2025[18] - The company received $275 million upfront from a royalty purchase agreement for 90% of future ex-U S royalties for Aspaveli[17] - Total revenue for 2Q 2025 was $1785 million, compared to $1997 million in 2Q 2024[18] EMPAVELI and Pipeline - EMPAVELI received U S FDA approval for C3G and primary IC-MPGN[10] - Apellis plans to initiate pivotal studies in DGF (Delayed Graft Function) and FSGS (Focal Segmental Glomerulosclerosis) by year end[10, 21] - APL-3007 reduced circulating C3 concentration by up to 90% in a Phase 1 healthy volunteer study[25] SYFOVRE - SYFOVRE's overall GA market share exceeds 60%[10] - Apellis initiated a Phase 2 study of SYFOVRE + APL-3007[10, 23] Market and Strategy - Approximately 5,000 C3G and primary IC-MPGN patients are estimated in the U S [28, 29] - The company aims to raise awareness about EMPAVELI as a disease-modifying therapy and establish it as the treatment of choice for relevant conditions[33, 34]
KBR(KBR) - 2025 Q2 - Earnings Call Presentation
2025-07-31 12:30
Financial Performance - Revenues for Q2 2025 reached $2.0 billion, a 6% increase year-over-year[14] - Adjusted EBITDA for Q2 2025 was $242 million, up 12% year-over-year[15] - Adjusted EBITDA margin expanded by 70 bps to 12.4%[16] - Year-to-date operating cash flow increased by 20%[46] - The company's net debt is $2.234 billion, with a net debt to TTM Adjusted EBITDA ratio of 2.4x[55] Backlog and Contract Wins - Total Backlog & Options stand at $21.6 billion[19] - The TTM Book-to-Bill ratio is 1.0x[19] - QTD Book-to-Bill ratio is 0.9x[19] - Mission Tech backlog & options is $17.8 billion[24] - Sustainable Tech backlog is $3.7 billion[24] Future Outlook - FY25 Revenues guidance is revised to $7.9 billion - $8.1 billion[56]
Intercontinental Exchange(ICE) - 2025 Q2 - Earnings Call Presentation
2025-07-31 12:30
July 31, 2025 1 CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS 2Q25 Earnings Supplement This presentation may contain "forward-looking statements" made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements regarding ICE's business that are not historical facts are forward- looking statements that involve risks, uncertainties and assumptions that are difficult to predict. Although we believe the expectations reflected in these forward-looking st ...